Clinical Trials Sponsored by Allergan Foundation

Total 20107 results

Allergan

Completed

Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease

Dry Eye Syndromes

Canada, Australia
Allergan

Completed

Post-Market Study of JUVÉDERM VOLIFT™ With Lidocaine for the Correction of Nasolabial Folds

Moderate to Severe Nasolabial Folds

Germany, Netherlands
Allergan

Completed

JUVEDERM® Ultra XC vs. Belotero Balance® for Perioral Lines

Patients With Moderate to Severe Perioral Lines

United States
Allergan

Completed

A Prospective, Open Label Study Evaluating JUVÉDERM® VOLBELLA With Lidocaine Treatment for the Correction of Skin Depressions in the Infra-orbital Area

Infra-orbital Skin Depressions

France
Allergan

Completed

A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

Alopecia

United States
Allergan

Completed

Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease

Dry Eye Syndromes

United States
Allergan

Completed

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine (ACHIEVE II)

Migraine, With or Without Aura

United States
Allergan

Completed

Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use

Irritable Bowel Syndrome With Diarrhea

United States, Canada
Allergan

Completed

An Adult Spasticity Registry of OnabotulinumtoxinA Treatment (ASPIRE)

Muscle Spasticity

Spain, Italy, United States, Germany, United Kingdom, Taiwan, France
Allergan

Completed

Study to Evaluate Efficacy and Tolerability of Two Topical Regimens in Subjects With Moderate to Severe Facial Photodamage Who Have Received Cosmetic Injections

Facial Photodamage

United States
Allergan

Completed

Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

Eyelash Hypotrichosis

Korea, Republic of
Allergan

Completed

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Skin Aging

United States
Allergan

Completed

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

Glabellar Lines | Nasolabial Fold | Crow's Feet Lines | Facial Rhytides

United States
Allergan

Completed

A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)

Migraine
Allergan

Completed

Split-face Study Comparing the Cosmetic Efficacy and Tolerability of Two Topical Products in Participants With Moderate Facial Melasma

Melasma

United States
Allergan

Completed

An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine

Migraine Disorders

Spain, Germany, Italy, Norway, Russian Federation, Sweden, United Kingdom
Allergan

Terminated

A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation

Premature Ejaculation

United States, United Kingdom
Allergan

Completed

A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions

Ulcer | Cystitis, Interstitial

United States, Canada
Allergan

Completed

Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD)

Macular Degeneration

Korea, Republic of, Australia, Portugal, Germany, United States, Philippines, Italy
Allergan

Completed

BOTOX® Treatment in Pediatric Lower Limb Spasticity

Cerebral Palsy | Muscle Spasticity | Pediatrics

United States, Korea, Republic of, Thailand, Hungary, Italy, Philippines, Poland, Russian Federation, Turkey
Allergan

Completed

BOTOX® Treatment in Pediatric Upper Limb Spasticity

Stroke | Cerebral Palsy | Muscle Spasticity | Pediatrics

United States, Korea, Republic of, Thailand, Hungary, Poland, Russian Federation, Turkey, Canada, Philippines
Allergan

Completed

Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma, Open-Angle

China
Allergan

Completed

A Safety and Efficacy Study of BOTOX® (Botulinum Toxin Type A) in Patients With Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in India

Overactive Bladder | Urinary Incontinence

India
Allergan

Completed

Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects

Renal Function

United States
Allergan

Completed

Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence From Neurogenic Detrusor Overactivity in Belgium

Urinary Incontinence

Belgium
Allergan

Completed

A Study of Hyaluronic Acid Injectable Gel (VYC-25L) for Restoration and Creation of Facial Volume in the Chin and Jaw

Chin Retrusion

France, Germany, Netherlands
Allergan

Completed

European New Texture Implant Clinical Experience With Round Breast Implants

Breast Augmentation

Germany, Sweden, United Kingdom
Allergan

Completed

European New Texture Implant Clinical Experience With Shaped Breast Implants

Breast Augmentation

Sweden
Allergan

Completed

A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine

Migraine Disorders

United States
Allergan

Completed

A Natural History Study of Patients With Dry Eye

Dry Eye

United States
Allergan

Withdrawn

BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic Migraine

Migraine Disorders
Allergan

Completed

A Study of Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration

Macular Degeneration

Japan
Allergan

Terminated

Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)

Alopecia | Alopecia, Androgenetic | Baldness

United States
Allergan

Completed

A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief

Dry Eye Syndromes

United States
Allergan

Completed

Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions

Skin Roughness

France
Allergan

Completed

BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb Spasticity

Muscle Spasticity

Poland, Canada, Korea, Republic of, Czech Republic, Germany, Hungary, United States, Russian Federation, United Kingdom
Allergan

Completed

Urinary Retention Rates in Clinical Practice After Treatment With OnabotulinumtoxinA for Idiopathic Overactive Bladder

Urinary Bladder, Overactive

United States
Allergan

Completed

Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye

Dry Eye Syndromes | Healthy Volunteers

United States
Allergan

Completed

A Safety, Tolerability, and Pharmacokinetics (PK) Study of AGN-223575 in Healthy Subjects

Healthy Volunteers

United States
Allergan

Completed

Perception of Facial Expression in Subjects With and Without Crow's Feet Lines

Healthy Volunteers

United States
Allergan

Completed

Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial

Overactive Bladder

United States
Allergan

Completed

Safety and Efficacy of Dexamethasone (OZURDEX®) Intravitreal Implant in Korea

Retinal Vein Occlusion

Korea, Republic of
Allergan

Completed

Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia

Cervical Dystonia

Poland, Germany, United States, Serbia, South Africa, Taiwan, Canada, Singapore, Russian Federation, Czech Republic, Thailand, Hungary, Philippines, United Kingdom, India, Slovakia
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Overactive Bladder

United Kingdom, Belgium, New Zealand, France, Russian Federation, Czech Republic, United States, Germany, Austria, Poland, Slovakia, Ukraine, Canada, Australia
Allergan

Completed

A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal (REVEAL)

Dry Eye Syndromes

Canada
Allergan

Completed

Safety and Effectiveness of Juvéderm® VOLUMA XC Injectable Gel for Cheek Augmentation

Mid-facial Volume Deficit Related to Aging

United States, Canada
Allergan

Terminated

A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma

Glaucoma

United Kingdom, Taiwan, Korea, Republic of, United States, Italy, Philippines, France
Allergan

Terminated

Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome

Fibromyalgia

Switzerland, United States, United Kingdom
Allergan

Completed

Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye

Dry Eye Syndromes

United States
Allergan

Completed

A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris

Acne Vulgaris

United States

3

Subscribe